A Study of GC101 TIL in Advanced Melanoma
Clinical trial NCT06703398 · RECRUITING
Trial details
- NCT number
- NCT06703398
- Sponsor
- Shanghai Juncell Therapeutics
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-20
- Primary completion
- 2026-05-12
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.